Skip to main content
Book cover

Cognitive Enhancement

  • Book
  • © 2015

Overview

  • Emphasizes individual cognitive domains, cutting across disease and disorder, with a perspective on the pharmacology for each
  • Maximizes insights into evolving themes that will bring cognitive research into a new era
  • Gives a broad overview on unique cognitive domains and the potential to treat with drugs the impairments in individual domains rather than in individual neurologic diseases or psychiatric disorders

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 228)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 chapters)

  1. Basic Approaches and Perspectives

  2. Cognitive Domains for Pharmacological Intervention: Implications for Neuropsychiatric and Neurological Illnesses

  3. Developmental Disorders, Alternative Approaches, and Emerging Technologies

Keywords

About this book

This book highlights the behavioral and neurobiological issues relevant for drug development, reviews evidence for an innovative approach for drug discovery and presents perspectives on multiple special topics ranging from therapeutic drug use in children, emerging technologies and non-pharmacological approaches to cognitive enhancement.

Editors and Affiliations

  • Department of Psychological and Brain Sciences, Boston University, Boston, USA

    Kathleen M. Kantak

  • Roche Pharmaceutical Research and Early Development; Neuroscience, Ophthalmology and Rare Diseases, F. Hoffmann-La Roche Ltd., Basel, Switzerland

    Joseph G. Wettstein

Bibliographic Information

Publish with us